Novum Pharma, LLC
FDA inspection history in Chicago, Illinois, 2019
- 1
- Form 483
Every document, by year
- Form 483
2019: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2019One Form 483, at Chicago, Illinois.
Cited most
Across all Novum Pharma observations on file
- 21 CFR 211.192Production record review2
- 21 CFR 211.22(a)Responsibilities of quality control unit2
- 21 CFR 211.180(e)(2)General requirements1
- 21 CFR 211.198(a)Complaint files1
- 21 CFR 310.305(c)(2)Records and reports concerning adverse drug experiences on marketed prescription drugs for human use without approved new drug applications1
The complete Novum Pharma file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Chicago, Illinois
One Form 483 · 2019 · 7 observations
Latest: Form 483, Sep 24, 2019 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2019-09-24 | 483 Form 483 | Chicago, Illinois | 7 | $99 |
Investigators on these documents
FEI number 3013162819 · most recent document Sep 24, 2019
About Novum Pharma, LLC
How many FDA Form 483s has Novum Pharma, LLC received?
FDA Intel has 1 Form 483 on file for Novum Pharma, LLC; the most recent is dated Sep 24, 2019.
When was Novum Pharma, LLC last inspected by FDA?
The most recent FDA inspection document on file for Novum Pharma, LLC is a Form 483 dated Sep 24, 2019, for the site in Chicago, Illinois.
What did FDA cite at Novum Pharma, LLC?
The regulations cited most in the observations on file for Novum Pharma, LLC are 21 CFR 211.192 (Production record review), 2 times; 21 CFR 211.22(a) (Responsibilities of quality control unit), 2 times; 21 CFR 211.180(e)(2) (General requirements), 1 time.